The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial

Background and aims: Despite strong mechanistic data, and promising results from in vitro and animal studies, the ability of probiotic bacteria to improve blood pressure and serum lipid concentrations in humans remains uncertain. The aim of this study was to determine the effect of Lactobacillus aci...

Full description

Bibliographic Details
Main Authors: Ivey, K., Hodgson, J., Kerr, Deborah, Thompson, P., Stojceski, B., Prince, R.
Format: Journal Article
Published: Elsevier 2015
Online Access:http://hdl.handle.net/20.500.11937/11032
_version_ 1848747696686366720
author Ivey, K.
Hodgson, J.
Kerr, Deborah
Thompson, P.
Stojceski, B.
Prince, R.
author_facet Ivey, K.
Hodgson, J.
Kerr, Deborah
Thompson, P.
Stojceski, B.
Prince, R.
author_sort Ivey, K.
building Curtin Institutional Repository
collection Online Access
description Background and aims: Despite strong mechanistic data, and promising results from in vitro and animal studies, the ability of probiotic bacteria to improve blood pressure and serum lipid concentrations in humans remains uncertain. The aim of this study was to determine the effect of Lactobacillus acidophilus La5 and Bifidobacterium animalis subsp lactis Bb12, provided in either yoghurt or capsule form, on home blood pressure and serum lipid profile. Methods and results:Following a 3-week washout period, 156 overweight men and women over 55 y were randomized to a 6-week double-blinded, factorial, parallel study. The four intervention groups were: A) probiotic yoghurt plus probiotic capsules; B) probiotic yoghurt plus placebo capsules; C) control milk plus probiotic capsules; and D) control milk plus placebo capsules. Each probiotic test article provided a minimum L. acidophilus La5 and B. animalis subsp. lactis Bb12 dose of 3.0 × 109 CFU/d. Home blood pressure monitoring, consisting of 7-day bi-daily repeat measurements, were collected at baseline and week 6. Fasting total cholesterol, low density lipoprotein cholesterol (LDLC), high density lipoprotein cholesterol (HDLC), and serum triglyceride were performed at baseline and week 6. When compared to control milk, probiotic yoghurt did not significantly alter blood pressure, heart rate or serum lipid concentrations (P > 0.05). Similarly, when compared to placebo capsules, supplementation with probiotic capsules did not alter blood pressure or concentrations of total cholesterol LDLC, HDLC, or triglycerides (P > 0.05). Conclusions: The probiotic strains L. acidophilus La5 and B. animalis subsp. lactis Bb12 did not improve cardiovascular risk factors.
first_indexed 2025-11-14T06:53:15Z
format Journal Article
id curtin-20.500.11937-11032
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T06:53:15Z
publishDate 2015
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-110322017-09-13T14:53:52Z The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial Ivey, K. Hodgson, J. Kerr, Deborah Thompson, P. Stojceski, B. Prince, R. Background and aims: Despite strong mechanistic data, and promising results from in vitro and animal studies, the ability of probiotic bacteria to improve blood pressure and serum lipid concentrations in humans remains uncertain. The aim of this study was to determine the effect of Lactobacillus acidophilus La5 and Bifidobacterium animalis subsp lactis Bb12, provided in either yoghurt or capsule form, on home blood pressure and serum lipid profile. Methods and results:Following a 3-week washout period, 156 overweight men and women over 55 y were randomized to a 6-week double-blinded, factorial, parallel study. The four intervention groups were: A) probiotic yoghurt plus probiotic capsules; B) probiotic yoghurt plus placebo capsules; C) control milk plus probiotic capsules; and D) control milk plus placebo capsules. Each probiotic test article provided a minimum L. acidophilus La5 and B. animalis subsp. lactis Bb12 dose of 3.0 × 109 CFU/d. Home blood pressure monitoring, consisting of 7-day bi-daily repeat measurements, were collected at baseline and week 6. Fasting total cholesterol, low density lipoprotein cholesterol (LDLC), high density lipoprotein cholesterol (HDLC), and serum triglyceride were performed at baseline and week 6. When compared to control milk, probiotic yoghurt did not significantly alter blood pressure, heart rate or serum lipid concentrations (P > 0.05). Similarly, when compared to placebo capsules, supplementation with probiotic capsules did not alter blood pressure or concentrations of total cholesterol LDLC, HDLC, or triglycerides (P > 0.05). Conclusions: The probiotic strains L. acidophilus La5 and B. animalis subsp. lactis Bb12 did not improve cardiovascular risk factors. 2015 Journal Article http://hdl.handle.net/20.500.11937/11032 10.1016/j.numecd.2014.07.012 Elsevier restricted
spellingShingle Ivey, K.
Hodgson, J.
Kerr, Deborah
Thompson, P.
Stojceski, B.
Prince, R.
The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial
title The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial
title_full The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial
title_fullStr The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial
title_full_unstemmed The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial
title_short The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial
title_sort effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial
url http://hdl.handle.net/20.500.11937/11032